(Q51612890)

English

Effect of 6 months' gliclazide treatment on insulin release and sensitivity to endogenous insulin in NIDDM: role of initial CSII-induced normoglycemia

scientific article published on January 1, 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/1794269

Effect of 6 months' gliclazide treatment on insulin release and sensitivity to endogenous insulin in NIDDM: role of initial CSII-induced normoglycemia (English)

1 reference

10.1016/0168-8227(91)90011-2

https://api.crossref.org/works/10.1016/0168-8227(91)90011-2

27 November 2022

1 reference

based on heuristic

inferred from title

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1794269

27 November 2022

1 reference

10.1016/0168-8227(91)90011-2

https://api.crossref.org/works/10.1016/0168-8227(91)90011-2

27 November 2022

internal medicine

1 reference

10.1016/0168-8227(91)90011-2

https://api.crossref.org/works/10.1016/0168-8227(91)90011-2

27 November 2022

Benjamin Glaser

3

object named as

B. Glaser

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1794269

27 November 2022

author name string

L. Della Casa

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1794269

27 November 2022

G. del Rio

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1794269

27 November 2022

E. Cerasi

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1794269

27 November 2022

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1794269

27 November 2022

publication date

1 January 1991

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/1794269

full work available at URL

https://api.elsevier.com/content/article/PII:0168822791900112?httpAccept=text/xml

1 reference

10.1016/0168-8227(91)90011-2

https://api.crossref.org/works/10.1016/0168-8227(91)90011-2

27 November 2022

https://api.elsevier.com/content/article/PII:0168822791900112?httpAccept=text/plain

1 reference

10.1016/0168-8227(91)90011-2

https://api.crossref.org/works/10.1016/0168-8227(91)90011-2

27 November 2022

Diabetes Research and Clinical Practice

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/1794269

14 Suppl 2

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/1794269

S69-78

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/1794269

Effect of chronic sulfonylurea therapy on plasma insulin and proinsulin levels

2

1 reference

10.1016/0168-8227(91)90011-2

https://api.crossref.org/works/10.1016/0168-8227(91)90011-2

27 November 2022

Effects of Glipizide and Food Intake on the Blood Levels of Glucose and Insulin in Diabetic Patients

3

1 reference

10.1016/0168-8227(91)90011-2

https://api.crossref.org/works/10.1016/0168-8227(91)90011-2

27 November 2022

Effects of tolazamide and exogenous insulin on insulin action in patients with non-insulin-dependent diabetes mellitus

5

1 reference

10.1016/0168-8227(91)90011-2

https://api.crossref.org/works/10.1016/0168-8227(91)90011-2

27 November 2022

Effect of chlorpropamide on glucose transport in rat adipocytes in the absence of changes in insulin binding and receptor-associated tyrosine kinase activity

6

1 reference

10.1016/0168-8227(91)90011-2

https://api.crossref.org/works/10.1016/0168-8227(91)90011-2

27 November 2022

Effect of glyburide on glycogen metabolism in cultured rat hepatocytes

7

1 reference

10.1016/0168-8227(91)90011-2

https://api.crossref.org/works/10.1016/0168-8227(91)90011-2

27 November 2022

Mechanisms of insulin resistance in obesity and noninsulin-dependent (type II) diabetes.

9

1 reference

10.1016/0168-8227(91)90011-2

https://api.crossref.org/works/10.1016/0168-8227(91)90011-2

27 November 2022

Banting lecture 1988. Role of insulin resistance in human disease

10

1 reference

10.1016/0168-8227(91)90011-2

https://api.crossref.org/works/10.1016/0168-8227(91)90011-2

27 November 2022

Relationship between glucose tolerance, insulin secretion, and insulin action in non-obese individuals with varying degrees of glucose tolerance

11

1 reference

10.1016/0168-8227(91)90011-2

https://api.crossref.org/works/10.1016/0168-8227(91)90011-2

27 November 2022

PLASMA-INSULIN RESPONSE TO SUSTAINED HYPERGLYCEMIA INDUCED BY GLUCOSE INFUSION IN HUMAN SUBJECTS

12

1 reference

10.1016/0168-8227(91)90011-2

https://api.crossref.org/works/10.1016/0168-8227(91)90011-2

27 November 2022

Dose-response relation between plasma-insulin and blood-glucose levels during oral glucose loads in prediabetic and diabetic subjects

13

1 reference

10.1016/0168-8227(91)90011-2

https://api.crossref.org/works/10.1016/0168-8227(91)90011-2

27 November 2022

Insulin deficiency and insulin resistance in type 2 (non-insulin-dependent) diabetes: quantitative contributions of pancreatic and peripheral responses to glucose homeostasis.

14

1 reference

10.1016/0168-8227(91)90011-2

https://api.crossref.org/works/10.1016/0168-8227(91)90011-2

27 November 2022

Insulin secretion in diabetes mellitus

15

1 reference

10.1016/0168-8227(91)90011-2

https://api.crossref.org/works/10.1016/0168-8227(91)90011-2

27 November 2022

First-phase insulin response to glucose in nonobese or obese subjects with glucose intolerance: analysis by C-peptide secretion rate

16

1 reference

10.1016/0168-8227(91)90011-2

https://api.crossref.org/works/10.1016/0168-8227(91)90011-2

27 November 2022

INSULIN DEFICIENCY IN NON-INSULIN-DEPENDENT DIABETES

17

1 reference

10.1016/0168-8227(91)90011-2

https://api.crossref.org/works/10.1016/0168-8227(91)90011-2

27 November 2022

Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion. A study in normal rats using chronic in vivo glucose infusions

19

1 reference

10.1016/0168-8227(91)90011-2

https://api.crossref.org/works/10.1016/0168-8227(91)90011-2

27 November 2022

One month's insulin treatment of type II diabetes: the early and medium-term effects following insulin withdrawal

21

1 reference

10.1016/0168-8227(91)90011-2

https://api.crossref.org/works/10.1016/0168-8227(91)90011-2

27 November 2022

Molecular defects in insulin action.

22

1 reference

10.1016/0168-8227(91)90011-2

https://api.crossref.org/works/10.1016/0168-8227(91)90011-2

27 November 2022

Basal and 24-h C-peptide and insulin secretion rate in normal man

23

1 reference

10.1016/0168-8227(91)90011-2

https://api.crossref.org/works/10.1016/0168-8227(91)90011-2

27 November 2022

Urinary C-peptide: an indicator of beta-cell secretion under different metabolic conditions.

24

1 reference

10.1016/0168-8227(91)90011-2

https://api.crossref.org/works/10.1016/0168-8227(91)90011-2

27 November 2022

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

28

1 reference

10.1016/0168-8227(91)90011-2

https://api.crossref.org/works/10.1016/0168-8227(91)90011-2

27 November 2022

Improved beta-cell function after intensive insulin treatment in severe non-insulin-dependent diabetes

29

1 reference

10.1016/0168-8227(91)90011-2

https://api.crossref.org/works/10.1016/0168-8227(91)90011-2

27 November 2022

Increase in insulin response after treatment of overt maturity-onset diabetes is independent of the mode of treatment.

30

1 reference

10.1016/0168-8227(91)90011-2

https://api.crossref.org/works/10.1016/0168-8227(91)90011-2

27 November 2022

The defective glucose sensitivity of the B cell in non insulin dependent diabetes. Improvement after twenty hours of normoglycaemia

31

1 reference

10.1016/0168-8227(91)90011-2

https://api.crossref.org/works/10.1016/0168-8227(91)90011-2

27 November 2022

Sulphonylurea therapy doubles B-cell response to glucose in type 2 diabetic patients.

32

1 reference

10.1016/0168-8227(91)90011-2

https://api.crossref.org/works/10.1016/0168-8227(91)90011-2

27 November 2022

Effect of glipizide on insulin secretion and insulin metabolism in obese type II diabetic patients.

33

1 reference

10.1016/0168-8227(91)90011-2

https://api.crossref.org/works/10.1016/0168-8227(91)90011-2

27 November 2022

Glyburide decreases insulin requirement, increases beta-cell response to mixed meal, and does not affect insulin sensitivity: effects of short- and long-term combined treatment in secondary failure to sulfonylurea

35

1 reference

10.1016/0168-8227(91)90011-2

https://api.crossref.org/works/10.1016/0168-8227(91)90011-2

27 November 2022

Identifiers

10.1016/0168-8227(91)90011-2

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/1794269

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 April 2018

http://europepmc.org/abstract/MED/1794269

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51612890&oldid=1779850958"